• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

塞浦路斯队列中 SCORE2 和 SCORE2-OP 风险算法的性能。

Performance of SCORE2 and SCORE2-OP risk algorithms in a Cypriot cohort.

机构信息

Vascular Screening and Diagnostic Center, Nicosia, Cyprus -

University of Nicosia Medical School, Nicosia, Cyprus -

出版信息

Int Angiol. 2022 Dec;41(6):492-499. doi: 10.23736/S0392-9590.22.04958-6. Epub 2022 Oct 26.

DOI:10.23736/S0392-9590.22.04958-6
PMID:36285529
Abstract

BACKGROUND

SCORE2 and SCORE2-OP algorithms and associated online calculators provide a new and easy method of estimating the 10-year cardiovascular risk in apparently healthy Europeans. The aim of the study was to determine the performance of these algorithms in terms of discrimination and calibration in the cohort of the Cyprus Epidemiological Study on Atherosclerosis (CESA), not only for the 10-year risk for myocardial infarction (MI), stroke and cardiovascular death, but also for all types of atherosclerotic cardiovascular events (ASCVE).

METHODS

SCORE2 and SCORE2-OP for low-risk regions were calculated in a non-diabetic subset of CESA consisting of 908 people (mean age±SD: 57.8±10.5; range 40-89; 58.8% female) using baseline risk factors. Mean follow-up was 13.2±3.7 years (range 1-17) with 89 primary endpoints (MI, stroke and cardiovascular death) and 136 secondary endpoints (primary endpoints, angina, cardiac failure, coronary revascularization, transient ischemic attack, claudication and critical limb ischemia).

RESULTS

The C-statistic for the prediction of the primary endpoint for all ages was 0.76 (95% CI 0.70 to 0.81) and the observed 10-year event rate was similar to the predicted one. However, the observed 10-year rate for secondary events was similar to the estimated one only when the algorithm for high-risk regions was used.

CONCLUSIONS

SCORE2 and SCORE2-OP moderate risk algorithms perform well in the Cypriot population for predicting the 10-year risk for MI, stroke and fatal cardiovascular disease. However, an estimate of the 10-year risk for all ASCVD events is best calculated from the high-risk algorithm.

摘要

背景

SCORE2 和 SCORE2-OP 算法及其相关在线计算器为评估明显健康的欧洲人群 10 年心血管风险提供了一种新的简便方法。本研究旨在评估这些算法在塞浦路斯动脉粥样硬化流行病学研究(CESA)队列中的区分度和校准度,不仅针对心肌梗死(MI)、卒中和心血管死亡的 10 年风险,还针对所有类型的动脉粥样硬化性心血管事件(ASCVE)。

方法

在 CESA 的一个非糖尿病亚组中,使用基线风险因素计算了适用于低危地区的 SCORE2 和 SCORE2-OP,该亚组包含 908 人(平均年龄±标准差:57.8±10.5;年龄范围 40-89;58.8%为女性)。平均随访时间为 13.2±3.7 年(范围 1-17),共发生 89 例主要终点事件(MI、卒中和心血管死亡)和 136 例次要终点事件(主要终点事件、心绞痛、心力衰竭、冠状动脉血运重建、短暂性脑缺血发作、跛行和严重肢体缺血)。

结果

预测所有年龄段主要终点的 C 统计量为 0.76(95%CI 0.70 至 0.81),观察到的 10 年事件发生率与预测值相似。然而,只有当使用高危地区算法时,观察到的 10 年次要事件发生率才与估计值相似。

结论

SCORE2 和 SCORE2-OP 中等风险算法在塞浦路斯人群中预测 MI、卒中和致命心血管疾病的 10 年风险表现良好。然而,最佳的所有 ASCVD 事件 10 年风险估计值应来自高危算法。

相似文献

1
Performance of SCORE2 and SCORE2-OP risk algorithms in a Cypriot cohort.塞浦路斯队列中 SCORE2 和 SCORE2-OP 风险算法的性能。
Int Angiol. 2022 Dec;41(6):492-499. doi: 10.23736/S0392-9590.22.04958-6. Epub 2022 Oct 26.
2
Validation of the SCORE2 risk prediction algorithm in a Portuguese population: A new model to estimate 10-year cardiovascular disease incidence in Europe.验证 SCORE2 风险预测算法在葡萄牙人群中的应用:一种用于估计欧洲人群 10 年心血管疾病发生率的新模型。
Rev Port Cardiol. 2024 Aug;43(8):437-444. doi: 10.1016/j.repc.2023.10.011. Epub 2024 Feb 21.
3
Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort.系统性冠状动脉风险评估 2 (SCORE2)和 SCORE2-老年人在 EPIC-Norfolk 前瞻性人群队列中的验证。
Eur J Prev Cardiol. 2024 Jan 25;31(2):182-189. doi: 10.1093/eurjpc/zwad318.
4
Validation of the European SCORE2 models in a Canadian primary care cohort.验证欧洲 SCORE2 模型在加拿大初级保健队列中的应用。
Eur J Prev Cardiol. 2024 Apr 18;31(6):668-676. doi: 10.1093/eurjpc/zwad352.
5
SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.SCORE2-OP 风险预测算法:估计四个地理风险地区老年人的新发心血管事件风险。
Eur Heart J. 2021 Jul 1;42(25):2455-2467. doi: 10.1093/eurheartj/ehab312.
6
[Cardiovascular risk assessment among patients with hypertension based on SCORE2 and SCORE-OP algorithms in black Africans].基于SCORE2和SCORE-OP算法对非洲裔高血压患者进行心血管风险评估
Ann Cardiol Angeiol (Paris). 2023 Jun;72(3):101602. doi: 10.1016/j.ancard.2023.101602. Epub 2023 May 13.
7
Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2.提高表面健康人群的 10 年心血管风险预测:在 SCORE2 基础上灵活添加风险修正因子。
Eur J Prev Cardiol. 2023 Oct 26;30(15):1705-1714. doi: 10.1093/eurjpc/zwad187.
8
Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study.应用颈动脉斑块总面积增加 SCORE2 对中年人群进行斑块成像的预后影响:ARteris 心血管结局(ARCO)队列研究。
Swiss Med Wkly. 2024 Jan 25;154:3735. doi: 10.57187/s.3735.
9
Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.将欧洲和美国的风险预测模型与多基因风险评分相结合,以完善心血管预防:CoLaus|PsyCoLaus 研究。
Eur J Prev Cardiol. 2023 May 9;30(7):561-571. doi: 10.1093/eurjpc/zwad012.
10
Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus.系统性冠状动脉风险评估 2 型糖尿病风险模型和动脉僵硬度对亚洲 2 型糖尿病患者心血管事件的预测价值。
J Diabetes Investig. 2024 Sep;15(9):1266-1275. doi: 10.1111/jdi.14231. Epub 2024 May 15.

引用本文的文献

1
Evaluating Cardiovascular Risk Factors Among Healthcare Professionals in Iran.评估伊朗医疗保健专业人员的心血管危险因素。
Med Sci Monit. 2025 Mar 15;31:e947409. doi: 10.12659/MSM.947409.
2
Cardiovascular risk profile with SCORE2 and SCORE2-OP: comparing Portugal, Spain, Italy, and France using the new European predictive models.使用SCORE2和SCORE2-OP评估心血管风险状况:运用新的欧洲预测模型比较葡萄牙、西班牙、意大利和法国
Front Cardiovasc Med. 2024 Dec 18;11:1509240. doi: 10.3389/fcvm.2024.1509240. eCollection 2024.